1.Effects of electroacupuncture stimulation on repetitive exercise-induced oxidative stress
Takahito HORINOUCHI ; Tomoya HAYASHI ; Keisaku KIMURA ; Yukihiro YOSHIDA ; Kenji KATAYAMA ; Tadashi YANO
Journal of the Japan Society of Acupuncture and Moxibustion 2012;62(1):38-46
[Objective]Daily repetitive exercise is known to be necessary for players in sports. In this study, to further explore the potential functions of acupuncture, we studied whether electroacupuncture (EA) stimulation has efficacy for repetitive exercise-induced oxidative stress.
[Methods]Six healthy male volunteers participated in both the non-treatment control group and the EA group in a crossover design. EA stimulation was applied to both the medial vastus muscles at 2 Hz and optimum intensity for each subject during ten min just before each exercise period. The subject performed ergometer exercise for 20 min with 75%of maximal oxygen uptake each day. This exercise period was performed once a day for three consecutive days. Blood lactate level (BLL) and plasma lipid peroxide (LP) concentration were measured as the markers for metabolism and oxidative stress, respectively. Visual Analogue Scale (VAS) was used to evaluate the individual level of fatigue due to exercise.
[Results]During and just after the exercise period, each value of BLL in the EA group was lower than the same points in the control group. Whereas LP concentrations before the exercise period on the first day in the control group was higher than the values in the same points on the second and third days. LP concentrations before the exercise period in the EA group were almost the same levels for three days. Furthermore, after the exercise period for the three consecutive days, LP concentrations and VAS in the EA group were lower than each value of the same points in the control group, and especially, the alteration of VAS showed a significant difference.
[Conclusion]The increased tendency of LP concentrations before the exercise period for three days in the control group indicated that repetitive exercise induced the accumulation of excess lipid peroxide. It might be suggested that EA stimulation suppressed subjective fatigue by an enhanced energy metabolic rate and decreased production of lipid peroxide. Hence the evidence strongly supported that EA stimulation might be useful for sports conditioning.
2.The Impact of Lifestyle Habits before, during, and after Primary Eradication of Helicobacter pylori: A Descriptive Study
Takashi HIROSE ; Ryohei YAMAMOTO ; Sumire SUZUKI ; Fumi MATSUKI ; Miyuki MORITA ; Hiroki INUZUKA ; Tatsuhiko SUZUKI ; Takahito YOSHIDA ; Yoshihiro ONISHI
An Official Journal of the Japan Primary Care Association 2025;48(1):2-10
Introduction: We aimed to evaluate the impact of lifestyle modifications on the risk of eradication failure in patients undergoing first-line therapy for Helicobacter pylori infection.Methods: A survey was conducted in a community pharmacy to assess changes in alcohol consumption, smoking, and high-fat diet intake before, during, and after first-line therapy for H. pylori infection in enrolled patients.Results: A total of 100 patients (response rate: 3.4%) were included in the analysis. Before therapy, 20 patients (20%) smoked, 35 patients (35%) consumed alcohol, and 91 patients (91%) had a high-fat diet. During therapy, the proportion of patients who changed their habits was 15.0% (3/20) for smoking, 71.4% (25/35) for alcohol consumption, and 28.6% (26/91) for high-fat diet. However, the continuation of these changes post-therapy was minimal.Conclusion: Among patients undergoing first-line therapy for H. pylori infection, lifestyle habits that increase the risk of eradication failure were prevalent, with many patients maintaining their habits during therapy except for alcohol consumption. These findings provide fundamental data for lifestyle counselling during eradication therapy.
3.The Burden of Health Care Provider Inquiries to Community Pharmacists: a Descriptive Cross-Sectional Study
Sumire SUZUKI ; Ryohei YAMAMOTO ; Takashi HIROSE ; Fumi MATSUKI ; Takahito YOSHIDA ; Yoshihiro ONISHI
Japanese Journal of Drug Informatics 2024;26(2):65-71
Objective: To determine the extent of pharmacists’ burden of inquiries from healthcare professionals in community pharmacies. Design: A descriptive cross-sectional study. Methods: A web-based survey was administered to pharmacists affiliated with Medical System Network Group, Inc.’s community pharmacies in Japan. The survey was conducted from February 15 to March 31, 2022. The primary outcome was the burden of inquiries from healthcare professionals and the secondary outcome was the level of burden by job category. Healthcare professionals were defined as physicians, nurses, pharmacists, administrators, care managers, and nursing home staff. To assess the degree of burden, participants were asked “Do you feel burdened by inquiries from health care professionals ? ” and their response was rated on a 5-point Likert scale (not at all, slightly, a little, a lot, and very much). The responses “a lot” and “very much” were combined and defined as “burdened.” To identify the causes of burden, factors of burden and inquiries were investigated. Results: Totally, 1,667 participants were recruited, of which 915 (54.9%) were included in the analysis (women: 62.6%). The participants had a median age of 38 years (interquartile range 31, 48), and worked as pharmacists for 12 years (interquartile range 5, 20). Nearly 13.5% of the respondents felt burdened by inquiries from healthcare professionals and 34.7% reported that physician inquiries were burdensome. The most common reason for feeling burdened was a lack of knowledge about the inquiries (77.3%). Conclusion: It was found that 13.5% of respondents felt burdened when dealing with inquiries from healthcare professionals to pharmacists. In particular, a high percentage of respondents felt burdened by inquiries from physicians. Further research is needed to clarify whether the introduction of a tool that matches the results of this study will reduce the burden of responding to inquiries.
4.Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer
Naoya MURAKAMI ; Miho WATANABE ; Takashi UNO ; Shuhei SEKII ; Kayoko TSUJINO ; Takahiro KASAMATSU ; Yumiko MACHITORI ; Tomomi AOSHIKA ; Shingo KATO ; Hisako HIROWATARI ; Yuko KANEYASU ; Tomio NAKAGAWA ; Hitoshi IKUSHIMA ; Ken ANDO ; Masumi MURATA ; Ken YOSHIDA ; Hiroto YOSHIOKA ; Kazutoshi MURATA ; Tatsuya OHNO ; Noriyuki OKONOGI ; Anneyuko I. SAITO ; Mayumi ICHIKAWA ; Takahito OKUDA ; Keisuke TSUCHIDA ; Hideyuki SAKURAI ; Ryoichi YOSHIMURA ; Yasuo YOSHIOKA ; Atsunori YOROZU ; Naonobu KUNITAKE ; Hiroyuki OKAMOTO ; Koji INABA ; Tomoyasu KATO ; Hiroshi IGAKI ; Jun ITAMI
Journal of Gynecologic Oncology 2023;34(3):e24-
Objective:
The purposes of this trial were to demonstrate the feasibility and effectiveness of the hybrid of intracavitary and interstitial brachytherapy (HBT) for locally advanced cervical cancer patients in the phase I/II prospective clinical trial.
Methods:
Patients with FIGO stage IB2-IVA uterine cervical cancer pretreatment width of which was ≥5 cm measured by magnetic resonance imaging were eligible for this clinical trial. The protocol therapy included 30–30.6 Gy in 15–17 fractions of whole pelvic radiotherapy concurrent with weekly CDDP, followed by 24 Gy in 4 fractions of HBT and pelvic radiotherapy with a central shield up to 50–50.4 Gy in 25–28 fractions. The primary endpoint of phase II part was 2-year pelvic progression-free survival (PPFS) rate higher than historical control of 64%.
Results:
Between October 2015 and October 2019, 73 patients were enrolled in the initial registration and 52 patients proceeded to the secondary registration. With the median follow-up period of 37.3 months (range, 13.9–52.9 months), the 2- PPFS was 80.7% (90% confidence interval [CI]=69.7%–88%). Because the lower range of 90% CI of 2-year PPFS was 69.7%, which was higher than the historical control ICBT data of 64%, therefore, the primary endpoint of this study was met.
Conclusion
The effectiveness of HBT were demonstrated by a prospective clinical study. Because the dose goal determined in the protocol was lower than 85 Gy, there is room in improvement for local control. A higher dose might have been needed for tumors with poor responses.